Authors: Trauzold, A Wermann, H Arlt, A Schutze, S Schafer, H Oestern, S Roder, C Ungefroren, H Lampe, E Heinrich, M Walczak, H Kalthoff, H

Citation: A. Trauzold et al., CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappa B contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells, ONCOGENE, 20(31), 2001, pp. 4258-4269

Authors: Ungefroren, H Kruse, ML Trauzold, A Roeschmann, S Roeder, C Arlt, A Henne-Bruns, D Kalthoff, H

Citation: H. Ungefroren et al., FAP-1 in pancreatic cancer cells: functional and mechanistic studies on its inhibitory role in CD95-mediated apoptosis, J CELL SCI, 114(15), 2001, pp. 2735-2746

Authors: Hinz, S Trauzold, A Boenicke, L Sandberg, C Beckmann, S Bayer, E Walczak, H Kalthoff, H Ungefroren, H

Citation: S. Hinz et al., Bcl-X-L protects pancreatic adenocarcinoma cells against CD95-and TRAIL-receptor-mediated apoptosis, ONCOGENE, 19(48), 2000, pp. 5477-5486

Authors: Schafer, H Lettau, P Trauzold, A Banasch, M Schmidt, WE

Citation: H. Schafer et al., Human PACAP response gene 1 (p22/PRG1): Proliferation-associated expression in pancreatic carcinoma cells, PANCREAS, 18(4), 1999, pp. 378-384

Authors: Schafer, H Arlt, A Trauzold, A Hunermann-Jansen, A Schmidt, WE

Citation: H. Schafer et al., The putative apoptosis inhibitor IEX-1L is a mutant nonspliced variant of p22(PRG1/IEX-1) and is not expressed in vivo, BIOC BIOP R, 262(1), 1999, pp. 139-145